Heritage Family Medicine And Wellness Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 3887 Scotts Plaza Dr, Jay, FL 32565 Phone: 850-981-0320 Fax: 850-981-0911 |
Jay Medical Clinic Clinic/Center - Rural Health Medicare: Medicare Enrolled Practice Location: 14088 Alabama St, Jay, FL 32565 Phone: 850-675-4546 Fax: 850-675-4548 |
Gastroenterology Associates Of Pensacola Pa Internal Medicine - Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 14114 Alabama St, Jay, FL 32565 Phone: 850-436-4563 Fax: 850-436-4570 |
John Stewart Michael Smith Md Family Medicine Medicare: Medicare Enrolled Practice Location: 14088 Alabama St, Jay, FL 32565 Phone: 850-675-4546 Fax: 850-675-4548 |
Jeffery S Kelley Md Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 14088 Alabama St, Jay, FL 32565 Phone: 850-675-4546 Fax: 850-675-4548 |
Gastroenterology Associates Of Pensacola Pa Internal Medicine - Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 14122 Alabama St., Jay, FL 32565 Phone: 850-436-4563 |
News Archive
In one year alone, over 4,500 children in the United States were hospitalized due to child abuse, and 300 of them died of their injuries, Yale School of Medicine researchers report in a new study. The findings are published in the March 2012 issue of Pediatrics.
The New York State Health Department has announced the creation of six regional demonstration projects totaling $6.5 million in grant awards to help address the complex health care needs of Medicaid recipients with chronic illness or at-risk for disease.
NanoLogix, a biotechnology innovator in the rapid detection and identification of live-cell microorganisms, announces preliminary results of MRSA testing at the University of Texas Health Science Center - Houston. Dr. Jonathan Faro, M.D., Ph.D. has found NanoLogix technology is able to deliver results for MRSA in 6 hours, as opposed to conventional culture-based testing wait times of 24 to 48 hours.
Teikoku Pharma USA announced today that it has submitted a 505(b)(2) New Drug Application (NDA) to the U.S. Food and Drug Administration for Docetaxel Injection Concentrate, Non-Alcohol Formula on February 26, 2015 and received an acknowledgment of the receipt from FDA.
A study led by a researcher at Albert Einstein College of Medicine of Yeshiva University has revealed a unique "partnership" between two types of bone marrow stem cells, which could lead to advances in regenerative medicine. The aim of regenerative medicine is to enable the body to repair, replace, restore or regenerate damaged or diseased cells, tissues and organs.
› Verified 5 days ago